US Stock MarketDetailed Quotes

PFE Pfizer

Watchlist
  • 25.530
  • -0.110-0.43%
Close Feb 14 16:00 ET
  • 25.760
  • +0.230+0.90%
Post 20:01 ET
144.68BMarket Cap18.11P/E (TTM)

Pfizer Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 29, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Oct 1, 2023
(Q2)Jul 2, 2023
(Q1)Apr 2, 2023
Total revenue
8.77%63.63B
31.46%17.76B
31.20%17.7B
2.13%13.28B
-19.51%14.88B
-41.70%58.5B
-44.37%13.51B
-40.40%13.49B
-53.12%13.01B
18.49B
Operating revenue
8.77%63.63B
31.46%17.76B
31.20%17.7B
2.13%13.28B
-19.51%14.88B
-41.70%58.5B
-44.37%13.51B
-40.40%13.49B
-53.12%13.01B
--18.49B
Cost of revenue
-28.46%17.85B
-21.87%5.91B
-43.22%5.26B
1.95%3.3B
-30.84%3.38B
-27.34%24.95B
-21.61%7.56B
52.88%9.27B
-62.57%3.24B
4.89B
Gross profit
36.47%45.78B
99.26%11.85B
194.53%12.44B
2.19%9.98B
-15.44%11.5B
-49.17%33.54B
-59.37%5.95B
-74.52%4.22B
-48.84%9.77B
13.6B
Operating expense
2.17%30.84B
0.13%8.67B
-0.24%7.15B
5.33%7.72B
3.84%7.3B
5.12%30.18B
-7.82%8.66B
3.79%7.17B
9.63%7.33B
7.03B
Selling and administrative expenses
-0.28%14.73B
-6.58%4.27B
-1.13%3.24B
6.29%3.72B
2.25%3.5B
8.00%14.77B
-1.51%4.58B
-3.24%3.28B
14.73%3.5B
--3.42B
Research and development costs
1.34%10.82B
7.82%3.04B
-4.17%2.6B
1.81%2.7B
-0.48%2.49B
-6.55%10.68B
-22.13%2.82B
0.56%2.71B
-5.93%2.65B
--2.51B
Depreciation amortization depletion
11.68%5.29B
7.26%1.36B
11.28%1.31B
10.39%1.31B
18.59%1.31B
31.14%4.73B
12.02%1.27B
43.43%1.18B
44.04%1.18B
--1.1B
-Depreciation and amortization
11.68%5.29B
7.26%1.36B
11.28%1.31B
10.39%1.31B
18.59%1.31B
31.14%4.73B
12.02%1.27B
43.43%1.18B
44.04%1.18B
--1.1B
Operating profit
344.72%14.94B
217.65%3.19B
279.24%5.28B
-7.25%2.26B
-36.06%4.2B
-90.99%3.36B
-151.57%-2.71B
-130.50%-2.95B
-80.34%2.44B
6.57B
Net non-operating interest income expense
-335.21%-2.55B
-620.25%-569M
-287.79%-667M
-237.50%-648M
-368.79%-661M
40.73%-585M
55.11%-79M
28.63%-172M
27.00%-192M
-141M
Non-operating interest income
-66.44%545M
-72.09%170M
-77.82%116M
-58.86%130M
-27.12%129M
547.01%1.62B
344.53%609M
647.14%523M
953.33%316M
--177M
Non-operating interest expense
39.93%3.09B
7.41%739M
12.66%783M
53.15%778M
148.43%790M
78.43%2.21B
119.81%688M
123.47%695M
73.38%508M
--318M
Other net income (expense)
-154.60%-4.37B
-96.19%-2.63B
143.04%99M
-8,695.00%-1.72B
24.84%-121M
-10.35%-1.72B
-953.50%-1.34B
45.63%-230M
102.85%20M
-161M
Gain on sale of security
-36.60%1.01B
-61.77%879M
213.49%446M
-353.33%-342M
105.54%25M
224.90%1.59B
2,773.75%2.3B
-250.89%-393M
124.95%135M
---451M
Earnings from equity interest
-79.80%102M
--0
14.50%150M
-74.36%40M
-229.41%-88M
15.83%505M
-1.31%151M
356.86%131M
4.70%156M
--68M
Special income (charges)
2.07%-6.35B
29.56%-3.91B
-31.56%-371M
-334.56%-1.65B
-60.54%-419M
-132.29%-6.48B
-475.05%-5.56B
71.88%-282M
-84.88%-379M
---261M
-Less：Restructuring and merger&acquisition
-10.94%2.42B
-68.49%751M
78.07%203M
509.55%1.21B
327.78%77M
105.45%2.72B
203.18%2.38B
-37.36%114M
17.06%199M
--18M
-Less:Impairment of capital assets
8.96%3.3B
6.74%2.95B
--0
--240M
-58.71%109M
618.29%3.02B
1,148.87%2.76B
--0
--0
--264M
-Less:Other special charges
23.15%633M
-6.09%216M
-55.47%57M
-7.27%153M
1,990.91%208M
-48.34%514M
634.88%230M
-78.56%128M
1,000.00%165M
---11M
-Write off
----
----
177.50%111M
173.33%41M
350.00%25M
336.54%227M
2,175.00%182M
135.29%40M
-25.00%15M
---10M
Other non- operating income (expenses)
-67.49%868M
-77.05%405M
-140.13%-126M
112.96%230M
-25.26%361M
28.86%2.67B
98.31%1.77B
-57.74%314M
203.85%108M
--483M
Income before tax
658.32%8.02B
99.76%-10M
240.66%4.72B
-104.54%-103M
-45.44%3.42B
-96.95%1.06B
-178.93%-4.13B
-137.24%-3.35B
-80.18%2.27B
6.27B
Income tax
97.49%-28M
47.04%-421M
124.27%234M
-88.73%-134M
-59.02%293M
-133.50%-1.12B
-445.65%-795M
-370.79%-964M
-104.52%-71M
715M
Net income
273.59%8.06B
112.44%418M
288.26%4.47B
-97.95%48M
-43.79%3.12B
-93.13%2.16B
-167.16%-3.36B
-127.55%-2.38B
-76.41%2.34B
5.56B
Net income continuous Operations
270.67%8.05B
112.32%411M
287.65%4.48B
-98.68%31M
-43.69%3.13B
-93.08%2.17B
-166.69%-3.34B
-127.62%-2.39B
-76.31%2.34B
--5.56B
Net income discontinuous operations
173.33%11M
126.92%7M
-166.67%-8M
950.00%17M
-600.00%-5M
-350.00%-15M
-1,400.00%-26M
157.14%12M
-105.88%-2M
--1M
Minority interest income
-20.51%31M
-11.11%8M
33.33%8M
-36.36%7M
-38.46%8M
11.43%39M
12.50%9M
-60.00%6M
83.33%11M
13M
Net income attributable to the parent company
279.00%8.03B
112.17%410M
287.45%4.47B
-98.24%41M
-43.80%3.12B
-93.25%2.12B
-167.46%-3.37B
-127.67%-2.38B
-76.51%2.33B
5.54B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
279.00%8.03B
112.17%410M
287.45%4.47B
-98.24%41M
-43.80%3.12B
-93.25%2.12B
-167.46%-3.37B
-127.67%-2.38B
-76.51%2.33B
5.54B
Basic earnings per share
273.68%1.42
111.67%0.07
288.10%0.79
-97.56%0.01
-43.88%0.55
-93.20%0.38
-167.42%-0.6
-127.27%-0.42
-76.84%0.41
0.98
Diluted earnings per share
281.08%1.41
111.67%0.07
285.71%0.78
-97.56%0.01
-43.30%0.55
-93.24%0.37
-168.97%-0.6
-127.81%-0.42
-76.30%0.41
0.97
Dividend per share
2.44%1.68
2.44%0.42
2.44%0.42
2.44%0.42
2.44%0.42
2.50%1.64
2.50%0.41
2.50%0.41
2.50%0.41
0.41
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 29, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Oct 1, 2023(Q2)Jul 2, 2023(Q1)Apr 2, 2023
Total revenue 8.77%63.63B31.46%17.76B31.20%17.7B2.13%13.28B-19.51%14.88B-41.70%58.5B-44.37%13.51B-40.40%13.49B-53.12%13.01B18.49B
Operating revenue 8.77%63.63B31.46%17.76B31.20%17.7B2.13%13.28B-19.51%14.88B-41.70%58.5B-44.37%13.51B-40.40%13.49B-53.12%13.01B--18.49B
Cost of revenue -28.46%17.85B-21.87%5.91B-43.22%5.26B1.95%3.3B-30.84%3.38B-27.34%24.95B-21.61%7.56B52.88%9.27B-62.57%3.24B4.89B
Gross profit 36.47%45.78B99.26%11.85B194.53%12.44B2.19%9.98B-15.44%11.5B-49.17%33.54B-59.37%5.95B-74.52%4.22B-48.84%9.77B13.6B
Operating expense 2.17%30.84B0.13%8.67B-0.24%7.15B5.33%7.72B3.84%7.3B5.12%30.18B-7.82%8.66B3.79%7.17B9.63%7.33B7.03B
Selling and administrative expenses -0.28%14.73B-6.58%4.27B-1.13%3.24B6.29%3.72B2.25%3.5B8.00%14.77B-1.51%4.58B-3.24%3.28B14.73%3.5B--3.42B
Research and development costs 1.34%10.82B7.82%3.04B-4.17%2.6B1.81%2.7B-0.48%2.49B-6.55%10.68B-22.13%2.82B0.56%2.71B-5.93%2.65B--2.51B
Depreciation amortization depletion 11.68%5.29B7.26%1.36B11.28%1.31B10.39%1.31B18.59%1.31B31.14%4.73B12.02%1.27B43.43%1.18B44.04%1.18B--1.1B
-Depreciation and amortization 11.68%5.29B7.26%1.36B11.28%1.31B10.39%1.31B18.59%1.31B31.14%4.73B12.02%1.27B43.43%1.18B44.04%1.18B--1.1B
Operating profit 344.72%14.94B217.65%3.19B279.24%5.28B-7.25%2.26B-36.06%4.2B-90.99%3.36B-151.57%-2.71B-130.50%-2.95B-80.34%2.44B6.57B
Net non-operating interest income expense -335.21%-2.55B-620.25%-569M-287.79%-667M-237.50%-648M-368.79%-661M40.73%-585M55.11%-79M28.63%-172M27.00%-192M-141M
Non-operating interest income -66.44%545M-72.09%170M-77.82%116M-58.86%130M-27.12%129M547.01%1.62B344.53%609M647.14%523M953.33%316M--177M
Non-operating interest expense 39.93%3.09B7.41%739M12.66%783M53.15%778M148.43%790M78.43%2.21B119.81%688M123.47%695M73.38%508M--318M
Other net income (expense) -154.60%-4.37B-96.19%-2.63B143.04%99M-8,695.00%-1.72B24.84%-121M-10.35%-1.72B-953.50%-1.34B45.63%-230M102.85%20M-161M
Gain on sale of security -36.60%1.01B-61.77%879M213.49%446M-353.33%-342M105.54%25M224.90%1.59B2,773.75%2.3B-250.89%-393M124.95%135M---451M
Earnings from equity interest -79.80%102M--014.50%150M-74.36%40M-229.41%-88M15.83%505M-1.31%151M356.86%131M4.70%156M--68M
Special income (charges) 2.07%-6.35B29.56%-3.91B-31.56%-371M-334.56%-1.65B-60.54%-419M-132.29%-6.48B-475.05%-5.56B71.88%-282M-84.88%-379M---261M
-Less：Restructuring and merger&acquisition -10.94%2.42B-68.49%751M78.07%203M509.55%1.21B327.78%77M105.45%2.72B203.18%2.38B-37.36%114M17.06%199M--18M
-Less:Impairment of capital assets 8.96%3.3B6.74%2.95B--0--240M-58.71%109M618.29%3.02B1,148.87%2.76B--0--0--264M
-Less:Other special charges 23.15%633M-6.09%216M-55.47%57M-7.27%153M1,990.91%208M-48.34%514M634.88%230M-78.56%128M1,000.00%165M---11M
-Write off --------177.50%111M173.33%41M350.00%25M336.54%227M2,175.00%182M135.29%40M-25.00%15M---10M
Other non- operating income (expenses) -67.49%868M-77.05%405M-140.13%-126M112.96%230M-25.26%361M28.86%2.67B98.31%1.77B-57.74%314M203.85%108M--483M
Income before tax 658.32%8.02B99.76%-10M240.66%4.72B-104.54%-103M-45.44%3.42B-96.95%1.06B-178.93%-4.13B-137.24%-3.35B-80.18%2.27B6.27B
Income tax 97.49%-28M47.04%-421M124.27%234M-88.73%-134M-59.02%293M-133.50%-1.12B-445.65%-795M-370.79%-964M-104.52%-71M715M
Net income 273.59%8.06B112.44%418M288.26%4.47B-97.95%48M-43.79%3.12B-93.13%2.16B-167.16%-3.36B-127.55%-2.38B-76.41%2.34B5.56B
Net income continuous Operations 270.67%8.05B112.32%411M287.65%4.48B-98.68%31M-43.69%3.13B-93.08%2.17B-166.69%-3.34B-127.62%-2.39B-76.31%2.34B--5.56B
Net income discontinuous operations 173.33%11M126.92%7M-166.67%-8M950.00%17M-600.00%-5M-350.00%-15M-1,400.00%-26M157.14%12M-105.88%-2M--1M
Minority interest income -20.51%31M-11.11%8M33.33%8M-36.36%7M-38.46%8M11.43%39M12.50%9M-60.00%6M83.33%11M13M
Net income attributable to the parent company 279.00%8.03B112.17%410M287.45%4.47B-98.24%41M-43.80%3.12B-93.25%2.12B-167.46%-3.37B-127.67%-2.38B-76.51%2.33B5.54B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 279.00%8.03B112.17%410M287.45%4.47B-98.24%41M-43.80%3.12B-93.25%2.12B-167.46%-3.37B-127.67%-2.38B-76.51%2.33B5.54B
Basic earnings per share 273.68%1.42111.67%0.07288.10%0.79-97.56%0.01-43.88%0.55-93.20%0.38-167.42%-0.6-127.27%-0.42-76.84%0.410.98
Diluted earnings per share 281.08%1.41111.67%0.07285.71%0.78-97.56%0.01-43.30%0.55-93.24%0.37-168.97%-0.6-127.81%-0.42-76.30%0.410.97
Dividend per share 2.44%1.682.44%0.422.44%0.422.44%0.422.44%0.422.50%1.642.50%0.412.50%0.412.50%0.410.41
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Earnings Season Underway
Earnings season is here. What to know?
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!